Literature DB >> 5637139

Impaired urinary concentration after vasopressin and its gradual correction in hypothalamic diabetes insipidus.

A R Harrington, H Valtin.   

Abstract

This study utilized rates with hereditary hypothalamic diabetes insipidus (D.I.) in order to explore possible mechanisms which prevent full urinary concentration after acute administration of vasopressin in hypothalamic D.I. and which correct this concentrating defect with prolonged therapy.IT WAS FOUND: (a) that the concentrating defect persisted even when the urinary osmolal excretion of D. I. rats was reduced to that of normal animals; (b) that the defect was not corrected more rapidly if larger doses of vasopressin were given; (c) that it persisted even when the D.I. rats were deprived of drinking water after vasopressin was given; (d) that there was osmotic equilibration between urine and renal papilla at a time when the concentrating defect was still evident; and (e) that the correction of the defect was associated with progressive and significant rise of the papillary osmolality. These studies appear to rule out osmotic diuresis, accumulation of exogenous vasopressin, persistent primary polydipsia, or delay in the induction of membrane permeability as causes for the concentrating defect. Rather, subnormal osmolality of the renal papilla, which can be corrected only gradually, accounts for the initial concentrating defect and the long time required for its correction. Reduction of water content and increase of urea content are primarily responsible for restoration of papillary osmolality to normal.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5637139      PMCID: PMC297196          DOI: 10.1172/JCI105746

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  VASOPRESSIN EFFECT ON URINARY CONCENTRATION IN RATS WITH HEREDITARY HYPOTHALAMIC DIABETES INSIPIDUS (BRATTLEBORO STRAIN).

Authors:  A R HARRINGTON; H VALTIN
Journal:  Proc Soc Exp Biol Med       Date:  1965-02

2.  Differential diagnosis between diabetes insipidus and compulsive polydipsia.

Authors:  F DIES; S RANGEL; A RIVERA
Journal:  Ann Intern Med       Date:  1961-04       Impact factor: 25.391

3.  Service of urea in renal water conservation.

Authors:  J D CRAWFORD; A P DOYLE; J H PROBST
Journal:  Am J Physiol       Date:  1959-03

4.  Effect of feeding protein and urea on renal concentrating ability in the rat.

Authors:  A HENDRIKX; F H EPSTEIN
Journal:  Am J Physiol       Date:  1958-12

5.  Enzymatic and metabolic adaptations in animals.

Authors:  W E KNOX; V H AUERBACH; E C LIN
Journal:  Physiol Rev       Date:  1956-04       Impact factor: 37.312

6.  The effect of vasopressin and of theophylline on the concentration of adenosine 3',5'-phosphate in the urinary bladder of the toad.

Authors:  J S Handler; R W Butcher; E W Sutherland; J Orloff
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

7.  The value of rats with hereditary hypothalamic diabetes insipidus for the bioassay of vasopressin.

Authors:  J J Jones; J Lee
Journal:  J Endocrinol       Date:  1967-03       Impact factor: 4.286

8.  Antidiuretic responses of rats with hereditary hypothalamic diabetes insipidus to vasopressin, oxytocin and nicotine.

Authors:  W H Sawyer; H Valtin
Journal:  Endocrinology       Date:  1967-01       Impact factor: 4.736

9.  Neurohypophysial principles in rats homozygous and heterozygous for hypothalamic diabetes insipidus (Brattleboro strain).

Authors:  H Valtin; W H Sawyer; H W Sokol
Journal:  Endocrinology       Date:  1965-10       Impact factor: 4.736

10.  Disorders of renal concentrating ability.

Authors:  F H Epstein
Journal:  Yale J Biol Med       Date:  1966-12
View more
  14 in total

1.  Renal response to blood volume expansion in Brattleboro rats after acute treatment with vasopressin.

Authors:  R Palluk; A T Veress; H Sonnenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

2.  Animal model of human disease: hereditary hypothalamic diabetes insipidus.

Authors:  H Valtin
Journal:  Am J Pathol       Date:  1976-06       Impact factor: 4.307

3.  [Potomania: re-evaluation of the diagnostic tests and unusual presentation with hydronephrosis and megabladder].

Authors:  C Caron; P Montambault; T Nawar; G E Plante; N Kandalaft
Journal:  Can Med Assoc J       Date:  1977-06-18       Impact factor: 8.262

4.  Effects of colchicine and vinblastine on the cellular action of vasopressin in mammalian kidney. A possible role of microtubules.

Authors:  T P Dousa; L D Barnes
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

5.  Micropuncture studies on the influence of antidiuretic hormone on tubular fluid reabsorption in rats with hereditary diabetes insipidus.

Authors:  J Schnermann; H Valtin; K Thurau; W Nagel; M Horster; H Fischbach; M Wahl; G Liebau
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

6.  Antidiuretic effect of beta-endorphin and morphine in Brattleboro rats: development of tolerance and physical dependence after chronic morphine treatment.

Authors:  J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

Review 7.  Molecular mechanisms of urea transport in health and disease.

Authors:  Janet D Klein; Mitsi A Blount; Jeff M Sands
Journal:  Pflugers Arch       Date:  2012-09-25       Impact factor: 3.657

8.  The effect of vasopressin (Pitressin) administration and dehydration on the concentration of solutes in renal fluids of rats with and without hereditary hypothalamic diabetes insipidus.

Authors:  J Lee; P G Williams
Journal:  J Physiol       Date:  1972-02       Impact factor: 5.182

9.  The effect of vasopressin on extracellular cation concentrations and muscle resting potentials in the rat.

Authors:  I B Gartside; A M Jones; J F Laycock; S J Walter
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

Review 10.  Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.

Authors:  Mirjam Christ-Crain; Wiebke Fenske
Journal:  Nat Rev Endocrinol       Date:  2016-01-22       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.